PLUR
Pluri Inc.
NASDAQ · Healthcare · Biotechnology · IL
$1.35
−1.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.87x
- Price / sales
- 15.00x
- Price / cash flow
- -0.79x
Enterprise value
- Enterprise value
- $45.9M
- EV / sales
- 42.51x
- EV / EBITDA
- -1.76x
- EV / EBIT
- -1.76x
- Market cap
- $16.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026